Literature DB >> 17970066

Altered gene expression by cisplatin in a human squamous cell lung carcinoma cell line.

Mari Yatomi1, Yuichi Takiguchi, Yoshiko Asaka-Amano, Makoto Arai, Yuji Tada, Katsushi Kurosu, Seiichiro Sakao, Yasunori Kasahara, Nobuhiro Tanabe, Koichiro Tatsumi, Naohiko Seki, Takayuki Kuriyama.   

Abstract

BACKGROUND: Substantial evidence has disclosed that some cytotoxic agents have complex activities in influencing signal transduction pathways in cells.
MATERIALS AND METHODS: cDNA microarray analysis was performed after exposing a human squamous cell carcinoma cell line, RERF-LC-AI, to low-dose cisplatin for 5 days. Up-regulated gene expressions were suppressed by small interfering RNA to investigate phenotypic alteration of the cells.
RESULTS: Among 30,000 genes screened, 42 genes showed increases or decreases in expression of more than 2-fold with cisplatin treatment. They included genes with functions involved in apoptosis, cell cycle regulation and DNA metabolism/repair. Suppression of the 5 most significantly altered genes by small interfering RNA resulted in partly reduced apoptosis without altering cytotoxicity of cisplatin.
CONCLUSION: Besides direct cytotoxic effects on cells, cisplatin may have indirect effects involving drug resistance, and synergistic effects with other agents.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17970066

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Cisplatin downregulates BCL2L12, a novel apoptosis-related gene, in glioblastoma cells.

Authors:  Mahdieh Sadat Taghavi; Azim Akbarzadeh; Reza Mahdian; Kayhan Azadmanesh; Gholamreza Javadi
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-05-25       Impact factor: 2.416

2.  CCN2 enhances resistance to cisplatin-mediating cell apoptosis in human osteosarcoma.

Authors:  Hsiao-Chi Tsai; Chun-Yin Huang; Hong-Lin Su; Chih-Hsin Tang
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.